Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nail Fatkhutdinov

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Targets|July 1, 2015
Potential therapeutic targets in ARID1A-mutated cancersBenjamin G Bitler, Nail Fatkhutdinov, Rugang Zhang
The Journal of Investigative Dermatology|December 17, 2020
ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in MelanomaTakeshi Fukumoto, Jianhuang Lin, Nail Fatkhutdinov, et al.
Molecular Cancer Research : MCR|June 15, 2016
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for MelanomaNail Fatkhutdinov, Katrin Sproesser, Clemens Krepler, et al.
Cancer Research|December 21, 2019
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian CancerTimothy Nacarelli, Takeshi Fukumoto, Joseph A Zundell, et al.
Cancer Research|July 18, 2019
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian CancerTakeshi Fukumoto, Nail Fatkhutdinov, Joseph A Zundell, et al.
Cancer Research|April 11, 2019
N<sup>6</sup>-Methylation of Adenosine of <i>FZD10</i> mRNA Contributes to PARP Inhibitor ResistanceTakeshi Fukumoto, Hengrui Zhu, Timothy Nacarelli, et al.
Nature Communications|February 21, 2020
Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescenceBo Zhao, Pingyu Liu, Takeshi Fukumoto, et al.
Cell Reports|December 21, 2017
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian CancerSergey Karakashev, Hengrui Zhu, Yuhki Yokoyama, et al.
Nature Communications|October 10, 2018
SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cellsShuai Wu, Nail Fatkhutdinov, Takeshi Fukumoto, et al.
The Journal of Cell Biology|November 2, 2016
HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene lociKatherine M Aird, Osamu Iwasaki, Andrew V Kossenkov, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Targets|July 1, 2015
Potential therapeutic targets in ARID1A-mutated cancersBenjamin G Bitler, Nail Fatkhutdinov, Rugang Zhang
The Journal of Investigative Dermatology|December 17, 2020
ARID2 Deficiency Correlates with the Response to Immune Checkpoint Blockade in MelanomaTakeshi Fukumoto, Jianhuang Lin, Nail Fatkhutdinov, et al.
Molecular Cancer Research : MCR|June 15, 2016
Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for MelanomaNail Fatkhutdinov, Katrin Sproesser, Clemens Krepler, et al.
Cancer Research|December 21, 2019
NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian CancerTimothy Nacarelli, Takeshi Fukumoto, Joseph A Zundell, et al.
Cancer Research|July 18, 2019
HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian CancerTakeshi Fukumoto, Nail Fatkhutdinov, Joseph A Zundell, et al.
Cancer Research|April 11, 2019
N<sup>6</sup>-Methylation of Adenosine of <i>FZD10</i> mRNA Contributes to PARP Inhibitor ResistanceTakeshi Fukumoto, Hengrui Zhu, Timothy Nacarelli, et al.
Nature Communications|February 21, 2020
Topoisomerase 1 cleavage complex enables pattern recognition and inflammation during senescenceBo Zhao, Pingyu Liu, Takeshi Fukumoto, et al.
Cell Reports|December 21, 2017
BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian CancerSergey Karakashev, Hengrui Zhu, Yuhki Yokoyama, et al.
Nature Communications|October 10, 2018
SWI/SNF catalytic subunits' switch drives resistance to EZH2 inhibitors in ARID1A-mutated cellsShuai Wu, Nail Fatkhutdinov, Takeshi Fukumoto, et al.
The Journal of Cell Biology|November 2, 2016
HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene lociKatherine M Aird, Osamu Iwasaki, Andrew V Kossenkov, et al.
Pageof 2